| Cat. No. | Product Name | Inquiry |
|---|---|---|
| X23-10-ZQ671 | COX inhibitor Deracoxib, Purity ≥98% | |
| X23-10-ZQ672 | COX inhibitor Bromfenac sodium hydrate, Purity ≥98% | |
| X23-10-ZQ673 | COX inhibitor Metamizole sodium hydrate, Purity ≥98% | |
| X23-10-ZQ690 | COX inhibitor Eicosatetraynoic acid, Purity ≥98% | |
| X23-10-ZQ693 | COX inhibitor GW-406381, Purity ≥98% | |
| X23-10-ZQ700 | COX inhibitor TFAP, Purity ≥98% | |
| X23-10-ZQ709 | COX inhibitor COX-2-IN-2, Purity ≥98% | |
| X23-10-ZQ716 | COX inhibitor Thioflosulide, Purity ≥98% | |
| X23-10-ZQ717 | COX inhibitor S-2474, Purity ≥98% | |
| X23-10-ZQ737 | COX inhibitor Etoricoxib D4, Purity ≥98% | |
| X23-10-ZQ743 | COX inhibitor CAY10404, Purity ≥98% | |
| X23-10-ZQ744 | COX inhibitor Mofezolac, Purity ≥98% | |
| X23-10-ZQ745 | COX inhibitor Pamicogrel, Purity ≥98% |
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.